SRCIN1 and colorectal cancer: An in-depth study on how VEGF signaling is promoted by miR-181a in preclinical models of colorectal cancer identified SRC kinase signaling inhibitor 1 (SRCIN1), an angiogenesis suppressor, as a key target of miR-181a [8].